Salud financiera de hoja de balance de Scentre Group

Salud financiera controles de criterios 1/6

Scentre Group tiene un patrimonio de accionistas total de A$18.0B y una deuda total de A$15.6B, lo que sitúa su ratio deuda-patrimonio en 86.7%. Sus activos y pasivos totales son A$35.7B y A$17.6B respectivamente. El BAIT de Scentre Group es de A$1.7B, por lo que su ratio de cobertura de intereses es de 3.6. Tiene efectivo e inversiones a corto plazo que ascienden a A$449.2M.

Información clave

86.7%

Ratio deuda-patrimonio

AU$15.63b

Deuda

Ratio de cobertura de intereses	3.6x
Efectivo	AU$449.20m
Patrimonio	AU$18.02b
Total pasivo	AU$17.65b
Activos totales	AU$35.67b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Trade Alert: The Independent Non-Executive Director Of Scentre Group (ASX:SCG), Andrew Harmos, Has Sold Some Shares Recently

Mar 13

Scentre Group (ASX:SCG) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Feb 25

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$914.2M) de SCG no cubren sus pasivos a corto plazo (A$3.2B).

Pasivo a largo plazo: Los activos a corto plazo (A$914.2M) de SCG no cubren sus pasivos a largo plazo (A$14.4B).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de SCG (84.2%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de SCG ha crecido de 65.5% a 86.7% en los últimos 5 años.

Cobertura de la deuda: La deuda de SCG no está bien cubierta por el flujo de caja operativo (6.9%).

Cobertura de intereses: Los pagos de intereses de la deuda de SCG están bien cubiertos por el BAIT (3.6x cobertura).

Hoja de balance

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de Scentre Group

Salud financiera controles de criterios 1/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half dividend of AU$0.084 announced

Scentre Group to Report Fiscal Year 2023 Results on Feb 21, 2024

Scentre Group, Annual General Meeting, Apr 04, 2024

First half 2023 earnings released: FFO per share: AU$0.1 (vs AU$0.11 in 1H 2022)

Scentre Group to Report First Half, 2023 Results on Aug 22, 2023

Scentre Group Provides Dividend Guidance for the Year 2023

Independent Non-Executive Director recently bought AU$71k worth of stock

Independent Non-Executive Director recently bought AU$147k worth of stock

Full year 2022 earnings released: EPS: AU$0.058 (vs AU$0.17 in FY 2021)

Scentre Group Announces Estimated Ordinary Dividend for the Period of Six Months Ended December 31, 2022, Payable on February 28, 2023

Scentre Group, Annual General Meeting, Apr 05, 2023

Scentre Group to Report Fiscal Year 2022 Results on Feb 22, 2023

High number of new directors

Independent Non-Executive Director recently sold AU$58k worth of stock

High number of new directors

Scentre Group Announces Board Changes

High number of new directors

Independent Non-Executive Director recently bought AU$290k worth of stock

First half 2022 earnings released: EPS: AU$0.093 (vs AU$0.077 in 1H 2021)

Scentre Group Provides Dividend Guidance for the Year 2022

Scentre Group Announces Estimated Dividend for the Six Months Ended June 30, 2022, Payable on August 31, 2022

Scentre Group to Report Q2, 2022 Results on Aug 23, 2022

Consensus forecasts updated

Scentre Group Appoints Andrew Clarke as Chief Financial Officer, Effective from October 1, 2022

High number of new directors

Scentre Group Provides Earnings Guidance for the Year 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Scentre Group Announces Chief Executive Officer Succession

Scentre Group Announces Retirement of Steven Leigh from the Board as Non-Executive Director

Scentre Group Announces Distribution on Ordinary Stapled Securities for the Six Months Ended December 31, 2021, Payable on February 28, 2022

Scentre Group to Report Fiscal Year 2021 Results on Feb 23, 2022

First half 2021 earnings released: EPS AU$0.077 (vs AU$0.69 loss in 1H 2020)

New 90-day high: AU$2.96

Trade Alert: The Independent Non-Executive Director Of Scentre Group (ASX:SCG), Andrew Harmos, Has Sold Some Shares Recently

Scentre Group (ASX:SCG) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2020 earnings released: AU$0.72 loss per share (vs AU$0.22 profit in FY 2019)

Revenue and earnings beat expectations

What You Need To Know About Scentre Group's (ASX:SCG) Investor Composition

Scentre Group to Report Fiscal Year 2020 Results on Feb 24, 2021

Scentre Group, Annual General Meeting, Apr 08, 2021

How Should Investors Feel About Scentre Group's (ASX:SCG) CEO Remuneration?

New 90-day high: AU$2.94

Scentre Group (ASX:SCG) Insiders Increased Their Holdings

New 90-day high: AU$2.38

New 90-day high: AU$2.34

Scentre Group(ASX:SCG) dropped from S&P/ASX 20 Index

Independent Director recently bought AU$206k worth of stock

Earnings released

Analysts update estimates

How Much Are Scentre Group (ASX:SCG) Insiders Spending On Buying Shares?

Perron Group Limited completed the acquisition of 50% stake in Westfield Burwood from Scentre Group (ASX:SCG).

Scentre Group to Report First Half, 2020 Results on Aug 25, 2020

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera